The Latest in Lymphoma & Plasma Cell Disorders

Antibody shows promise for treating CLL

December 22, 2015

Survey reveals need to evaluate EOL discussions

December 22, 2015

Venetoclax produces deep responses in ultra-high-risk CLL

December 17, 2015

Surprising finding in upfront use of idelalisib monotherapy

December 15, 2015

Group finds inconsistencies in genome sequencing procedures

December 15, 2015

Combination offers ‘important new option’ for CLL, team says

December 13, 2015

FDA approves rapid-infusion bendamustine

December 11, 2015

Triplet disappoints in follicular lymphoma trial

December 11, 2015

2nd-gen BTK inhibitor may be safer, team says

December 10, 2015

FDA grants KTE-C19 breakthrough designation

December 10, 2015

CAR exhibits activity in resistant B-cell malignancies

December 9, 2015

Ibrutinib ‘treatment of choice’ in rel/ref MCL

December 8, 2015

Cancer drug prices vary widely from country to country

December 7, 2015

Complete excision most effective for BI-ALCL

December 3, 2015

Lymphoma & Plasma Cell Disorders

Trial of ofatumumab in FL stopped early

November 25, 2015